Clinical Study of TISSIUM’s COAPTIUM Connect Atraumatic Sutureless Nerve Coaptation System Is Underway in Australia
Paris, France, Boston, USA, March 30th, 2023 — TISSIUM, a privately-owned medical technology company developing biomorphic programmable polymers for atraumatic tissue reconstruction, announced today the successful implantations of the first patients with its COAPTIUM Connect Sutureless Nerve Coaptation System as part of its peripheral nerve repair study in Australia. The procedures were performed as part of an ongoing clinical trial conducted by Dr Michael Wagels at the Princess Alexandra Hospital, supported by the Translational Research Institute’s Translational Trials team, and by Prof Randy Bindra at the Gold Coast University Hospital.
The COAPTIUM Connect System has been designed for sutureless and consistent nerve repair. It leverages TISSIUM’s unique biopolymer platform and is comprised of a biodegradable light-activated surgical adhesive and a protective coaptation “chamber.”
“I am honored to have treated the first patient with the COAPTIUM Connect System. The sutureless nerve coaptation was straightforward, and the patient has recovered well. I am optimistic that COAPTIUM Connect can bring us a step closer to better nerve repair outcomes,” said Dr. Michael Wagels, Director of the Australian Centre for Complex Integrated Surgical Solutions, Department of Plastic and Reconstructive Surgery, Princess Alexandra Hospital.
Dr. Randy Bindra, Professor of Orthopaedic Surgery at the Gold Coast University Hospital and Griffith University School of Medicine and principal trial investigator at Gold Coast University Hospital added: “We are thrilled that this important study has started in Australia with the enrollment of the first patients. This novel technology has the potential to present a significant advancement for repair of the injured nerve. “TISSIUM’s technology has the potential to revolutionize the field of tissue reconstruction in multiple therapeutic areas” said Christophe Bancel, CEO of TISSIUM, “The first clinical use of COAPTIUM Connect Sutureless Nerve Coaptation System is the culmination of years of research and an important step toward our goal of enabling atraumatic tissue repair.”